Skip to main content
OpenTrials
Completed

NCT Number: NCT02723305

Cardiometabolic Profiles of Boys With Klinefelter Syndrome

This study plans to learn more about how to measure the way the the body's energy system works in boys with Klinefelter syndrome, including the heart, lungs, muscles, and liver. This is important to know so that investigators understand how hormones and an extra X chromosome relate to diseases such as diabetes, extra weight gain, heart disease and liver diseases.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Klinefelter syndrome (KS) is the most common chromosomal abnormality in males and is associated with primary gonadal failure in adolescence and a high morbidity and mortality from cardiovascular-related diseases (CVD) in adulthood. Recent studies in children and adolescent boys with KS have found a high prevalence of CVD risk markers, however the underlying mechanisms have not been explored. Our central hypothesis is that pubertal boys with KS have relative testosterone deficiency resulting in abnormal energy metabolism that predisposes them to later CVD, and that exogenous testosterone will modify these abnormalities.

In this study, investigators will measure markers of cardiometabolic risk in pubertal boys with KS.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male, 47,XXY karyotype (non-mosaic)
  • Age 12-17 years
  • Tanner stage 3-5 pubic hair
  • T naïve group only: No exogenous androgen exposure within the past 5 years
  • T exposed group only: currently on topical testosterone, with duration of treatment between 1-2 years.

Exclusion criteria

  • Cognitive, psychiatric, or physical impairment resulting in inability to tolerate the study procedures
  • MRI incompatible metal
  • Diagnosis of type 1 or type 2 diabetes
  • Hypertension greater than 140/90 mm/Hg at rest (would make exercise studies unsafe)
  • Weight > 300 lbs (limit for DEXA)
  • Testosterone treatment for <1 year or >2 years

Treatment and study plan

No intervention

Other

Primary outcomes

  1. VO2 peak

    Time frame: baseline

    The primary outcome will be peak oxygen consumption (VO2 peak) during exercise on a bicycle ergometer

Secondary outcomes

  1. Body composition

    Time frame: baseline

    Percent body fat by dual-energy x-ray absorptiometry

  2. Liver fat

    Time frame: baseline

    Intrahepatic fat by abdominal magnetic resonance imaging

  3. Muscle mitochondrial metabolism

    Time frame: baseline

    Rate of mitochondrial phosphorylation by 31-phosphorus magnetic resonance spectroscopy of the calf muscles

  4. Insulin sensitivity

    Time frame: baseline

    oral disposition index with Glucola

Sponsors and collaborators

Lead sponsor

University of Colorado, Denver

Other

Registry information

Official study title

Cardiometabolic Profiles of Pubertal Boys With Klinefelter Syndrome With or Without One Year of Exogenous Testosterone Treatment

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Mar 30, 2016
Registry last updated
Mar 8, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.